Sign In
Buy SAN
$14.10
-0.0100 (-0.0709%)
At Close: Jul 31, 2026
Press Release: Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich R&D news flow in Immunology and Rare Disease
05:30am, Thursday, 28'th Jul 2022 GlobeNewswire Inc.
Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich R&D news flow in Immunology and Rare Disease
Communiqué de presse : Forte performance au T2 : hausse des perspectives 2022 et nombreuses avancées R&D en immunologie et maladies rares
05:30am, Thursday, 28'th Jul 2022 GlobeNewswire Inc.
Forte performance au T2 : hausse des perspectives 2022 et nombreuses avancées R&D en immunologie et maladies rares
Santander Brasil beats net profit forecasts but raises loan-loss provisions
05:07am, Thursday, 28'th Jul 2022
Banco Santander Brasil SA's second-quarter net income beat market expectations but loan-loss provisions rose sharply against a challenging macroeconomic backdrop, data released on Thursday showed.
Santander Chile CEO to step down in August
04:32pm, Wednesday, 27'th Jul 2022
Santander's Chile chief executive, Miguel Mata Huerta, will step down on August 1, the banking unit said in a filing Wednesday to the Chilean stock market.
Santander CIB, SAP Team to Digitize Transaction Banking
03:03pm, Wednesday, 27'th Jul 2022
Santander Corporate and Investment Banking (CIB) announced Tuesday (July 26) that it has entered a new strategic partnership with SAP Spain, aiming to boost digitalization across Global Transaction Ba
Are Investors Undervaluing Banco Santander (SAN) Right Now?
01:40pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Santander withdraws bidding for Citi’s Banamex
07:39am, Friday, 22'nd Jul 2022 MarketWatch
The Spanish bank said it had submitted a non-binding offer for the unit, but it won't be continuing in the next stages of the process, Santander said in a statement.
Analyst says Santander's exit from Banamex bidding may ease capital concerns
07:19am, Friday, 22'nd Jul 2022
Jefferies analyst Benjie Creelan-Sandford said Friday the confirmation from Banco Santander S.A. SAN, +1.64% that it won't continue bidding for Citigroup Inc.'s C, +0.27% Banamex unit in Mexico should
Santander says is out of Citigroup's sale of Citibanamex
02:27am, Friday, 22'nd Jul 2022
Spain's Santander said on Friday it was out of the process to buy Citigroup's Mexican unit.
Sanofi: Information concerning the total number of voting rights and shares – June 2022
04:52pm, Wednesday, 20'th Jul 2022 GlobeNewswire Inc.
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement
Sanofi: Informations relatives au nombre de droits de vote et d'actions – JUIN 2022
04:52pm, Wednesday, 20'th Jul 2022 GlobeNewswire Inc.
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marc
Santander bank's former Midtown office tower scooped up
12:23pm, Sunday, 17'th Jul 2022
We first reported on the pending acquisition from Florida-based MEK Management Services in April.
Press Release: Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis
05:00am, Thursday, 14'th Jul 2022 GlobeNewswire Inc.
Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis
Communiqué de presse: Résultats positifs de phase III pour Dupixent® (dupilumab) dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 1 à 11 ans
05:00am, Thursday, 14'th Jul 2022 GlobeNewswire Inc.
Résultats positifs de phase III pour Dupixent® (dupilumab) dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 1 à 11 ans
Is WisdomTree Europe Hedged Equity ETF (HEDJ) a Strong ETF Right Now?
10:20am, Wednesday, 13'th Jul 2022 Zacks Investment Research
Smart Beta ETF report for HEDJ
